NEW YORK --(BUSINESS WIRE)--Mar. 8, 2022-- Schrödinger , Inc. (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, today announced that new preclinical data on its small-molecule Wee1 inhibitors will be presented during a poster
NEW YORK --(BUSINESS WIRE)--Feb. 28, 2022-- Schrödinger (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, today announced that management will participate at the Truist Securities Life Sciences AI Symposium - Biotech & Tools .
Delivered Strong Fourth Quarter, with Software Revenue of $38.6 Million , a 55 Percent Increase over Fourth Quarter of 2020 Full Year 2021 Total Revenue of $137.9 Million , up 28 Percent Year-over-Year, with Full Year 2021 Software Revenue of $113.2 Million , up 22 Percent Year-over-Year Provides
NEW YORK --(BUSINESS WIRE)--Feb. 17, 2022-- Schrödinger, Inc. (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, today reported that on February 14, 2022 , the company granted non-statutory stock options to purchase an aggregate
NEW YORK --(BUSINESS WIRE)--Feb. 10, 2022-- Schrödinger (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, will report its fourth quarter and full year 2021 financial results on Thursday, February 24, 2022 , after the financial
NEW YORK --(BUSINESS WIRE)--Feb. 8, 2022-- Schrödinger (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, today announced that management will provide a company overview at the SVB Leerink Virtual 11th Annual Global Healthcare
NEW YORK --(BUSINESS WIRE)--Jan. 20, 2022-- Schrödinger, Inc. (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, today reported that on January 16, 2022 , the company granted non-statutory stock options to purchase an aggregate
Acquisition Expands Schrödinger’s Leadership in Structure-Based Drug Discovery NEW YORK --(BUSINESS WIRE)--Jan. 18, 2022-- Schrödinger , Inc. (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, today announced the acquisition of
NEW YORK --(BUSINESS WIRE)--Jan. 5, 2022-- Schrödinger (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, today announced that management will participate in a fireside chat at the H.C. Wainwright BioConnect Conference .